2018-04-19 Hoersholm, Denmark, April 19, 2018 - Medical Prognosis Institute A/S (`MPI`) today announces that, as a consequence of an exercise of 340,000 warrants, the share capital in the company will increase by nominal DKK 17.000,00 and the number of shares will increase by 340,000. 300,000 warrants are exercise by MPI`s CEO Peter Buhl Jensen. The exercise was requested April 3, 2018 approved by the Board of Directors today. The remaining 40,000 warrants have been exercised by other current and former employees of the company. The dilution for existing shareholders will be approximately 1.4 %. The increase has been executed without any pre-emption...
|
